Alpine Global Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $1.1 Million - $1.4 Million	-2,306 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $1.26 Million - $1.52 Million	2,306 New	2,306 $1.29 Million
Q1 2020 Apr 09, 2020	SELL	$336.18 - $494.43 $448,464 - $659,569	-1,334 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$274.13 - $376.51 $365,689 - $502,264	1,334 New	1,334 $501,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $263,234 - $344,943	-734 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $316,632 - $369,936	734	734 $328,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.